Dr. Rochon obtained her Ph.D. in the Department of Communication Sciences and Disorders at McGill University, where her doctoral dissertation was on sentence comprehension impairments in Alzheimer's Disease. She subsequently completed a postdoctoral fellowship at Moss Rehabilitation Research Institute, Moss Rehab Hospital (Philadelphia, PA), where she worked with Dr. Myrna Schwartz and colleagues. At Moss, she continued her studies of language comprehension impairments in Alzheimer's Disease, in addition to working on a large project designed to evaluate a new treatment ("mapping therapy") for individuals with nonfluent aphasia. Previous to joining the Department of Speech-Language Pathology at the University of Toronto, Dr. Rochon was Silverman Scientist in the Kunin-Lunenfeld Clinical Research Unit and the Department of Communication Disorders at Baycrest in Toronto. Dr. Rochon is a Senior Scientist and member of the Communication Research Team at Toronto Rehab. Dr. Rochon is also an Associate Member of the Heart and Stroke Foundation Canadian Partnership for Stroke Recovery.
- Professional InterestDr. Rochon's research and teaching interests relate to the theory, assessment and treatment of aphasia, dementia and related disorders. Research interests lie in identifying the nature and components of linguistic and cognitive impairments subsequent to brain damage, and in developing new treatment approaches for language impairments in aphasia. In addition, she is interested in language processes in normal aging.
- Current ResearchOngoing studies in Dr. Rochon's lab are designed to better characterize the nature and extent of language comprehension and production impairments in Alzheimer's disease and primary progressive aphasia (PPA). In a longitudinal study that is investigating the nature of the connected speech impairment in PPA, Dr. Rochon and collaborators are also using magnetic resonance imaging (MRI) and diffusion tenser imaging (DTI) to examine typical patterns of progression of pathology in the brain and to specify further the abnormalities that characterize the syndromes.
Other work involves the development and the assessment of new treatments for language impairments for patients who have had strokes. In addition, using functional magnetic resonance imaging (fMRI), Dr. Rochon and collaborators are researching the neural processing characteristics associated with changes in naming performance as a function of different treatment regimens for naming impairments in aphasia.
Research projects are funded by the Canadian Institute of Health Research (CIHR), the Heart and Stroke Foundation of Canada (HSFC), and Heart and Stroke Foundation Canadian Partnership for Stroke Recovery (HSFCPSR).
Can We Help Care Providers Communicate More Effectively With Persons Having Dementia Living in Long-Term Care Homes?
Am J Alzheimers Dis Other Demen. 2016 Nov 28;:
Exploratory analysis of real personal emergency response call conversations: considerations for personal emergency response spoken dialogue systems.
J Neuroeng Rehabil. 2016 Nov 14;13(1):97
Dement Geriatr Cogn Dis Extra. 2016 Sep-Dec;6(3):407-423
Am J Speech Lang Pathol. 2016 Oct 25;:1-12
Wh- questions and passive sentences in non-fluent variant PPA and semantic variant PPA: Longitudinal findings of an anagram production task.
Cogn Neuropsychol. 2016 Jun 24;:1-14
Behavioral and neuroimaging changes after naming therapy for semantic variant primary progressive aphasia.
Neuropsychologia. 2016 Jun 10;
Arch Phys Med Rehabil. 2016 Apr 7;
Profiling Speech and Pausing in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
PLoS One. 2016;11(1):e0147573
Int J Lang Commun Disord. 2015 Nov 27;
Int J Speech Lang Pathol. 2015 Mar 5;:1-6
Senior Scientist, Toronto Rehabilitation Institute (TRI)
Professor, Department of Speech-Language Pathology, Faculty of Medicine, University of Toronto
Co-Team Leader, Communication Team, Toronto Rehabilitation Institute